论文部分内容阅读
目的:了解妈富隆、安宫黄体酮联合治疗围绝经期功血的临床效果。方法:随机选取29例围绝经期功血患者作对照组,采用妈富隆治疗;另选取29例作研究组,采用妈富隆、安宫黄体酮联合治疗,对比各自用药后疗效。结果:研究组、对照组患者用药后控制出血时间分别为(31.2±1.5)h、(39.6±3.1)h;完全止血时间分别为(43.5±2.0)h、(65.34±5.8)h,组间比较差异显著(P<0.05);(2)研究组、对照组患者治疗总有效率分别为93.1%、65.51%,复发率分别为3.44%、20.68%,组间比较差异显著(P<0.05)。结论:妈富隆、安宫黄体酮联合治疗围绝经期功血效果显著,复发率低,可促患者早日康复。
Objective: To understand the clinical effect of Marvelon and Andong progesterone in treating peri-menopausal dysfunctional uterine bleeding. METHODS: Twenty-nine patients with peri-menopausal dysfunctional uterine bleeding were randomly selected as the control group and treated with Marvelon. Another 29 patients were selected as the study group and treated with Marvelon and Andong’s progesterone in combination. Results: The bleeding time in study group and control group after treatment was (31.2 ± 1.5) h and (39.6 ± 3.1) h respectively, and the complete hemostasis time was (43.5 ± 2.0) and (65.34 ± 5.8) (P <0.05); (2) The total effective rates of the study group and the control group were 93.1% and 65.51% respectively, the recurrence rates were 3.44% and 20.68% respectively, with significant difference between the two groups (P <0.05) . Conclusion: Marvelon and Andong progesterone combined treatment of peri-menopause dysfunctional uterine bleeding effect is significant, the recurrence rate is low, can promote the early recovery of patients.